GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (XSWX:BANB) » Definitions » Forward PE Ratio

Bachem Holding AG (XSWX:BANB) Forward PE Ratio : 0.00 (As of May. 11, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Bachem Holding AG Forward PE Ratio?

Bachem Holding AG's Forward PE Ratio for today is 0.00.

Bachem Holding AG's PE Ratio without NRI for today is 54.53.

Bachem Holding AG's PE Ratio for today is 54.42.


Bachem Holding AG Forward PE Ratio Historical Data

The historical data trend for Bachem Holding AG's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG Forward PE Ratio Chart

Bachem Holding AG Annual Data
Trend 2019-12 2020-12 2021-12 2022-12 2023-12 2024-01
Forward PE Ratio
35.59 59.52 62.50 44.05 34.97 33.11

Bachem Holding AG Semi-Annual Data
2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12
Forward PE Ratio 32.57 35.59 45.66 59.88 59.88 59.52 56.18 75.76 78.13 62.50 48.78 38.61 33.67 44.05 55.87 52.63 36.63 34.97

Competitive Comparison of Bachem Holding AG's Forward PE Ratio

For the Chemicals subindustry, Bachem Holding AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bachem Holding AG's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bachem Holding AG's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's Forward PE Ratio falls into.



Bachem Holding AG Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Bachem Holding AG  (XSWX:BANB) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Bachem Holding AG Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bachem Holding AG (XSWX:BANB) Business Description

Traded in Other Exchanges
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Bachem Holding AG (XSWX:BANB) Headlines

No Headlines